BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16955523)

  • 1. Precursor frequency can compensate for lower TCR expression in T cell competition during priming in vivo.
    Rechtsteiner G; Warger T; Hofmann M; Rammensee HG; Schild H; Radsak MP
    Eur J Immunol; 2006 Oct; 36(10):2613-23. PubMed ID: 16955523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
    Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
    Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell avidity determines the level of CTL activation.
    Hofmann M; Radsak M; Rechtsteiner G; Wiemann K; Günder M; Bien-Gräter U; Offringa R; Toes RE; Rammensee HG; Schild H
    Eur J Immunol; 2004 Jul; 34(7):1798-806. PubMed ID: 15214028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular interactions required for triggering alloantigen-specific cytolytic T lymphocytes.
    Kane KP; Sherman LA; Mescher MF
    J Immunol; 1989 Jun; 142(12):4153-60. PubMed ID: 2470815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen dose governs the shaping of CTL repertoires in vitro and in vivo.
    Kim M; Moon HB; Kim K; Lee KY
    Int Immunol; 2006 Mar; 18(3):435-44. PubMed ID: 16431877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell precursor frequency differentially affects CTL responses under different immune conditions.
    Ye Z; Ahmed KA; Huang J; Xie Y; Munegowda MA; Xiang J
    Biochem Biophys Res Commun; 2008 Mar; 367(2):427-34. PubMed ID: 18178159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses.
    Bedoui S; Prato S; Mintern J; Gebhardt T; Zhan Y; Lew AM; Heath WR; Villadangos JA; Segura E
    J Immunol; 2009 Apr; 182(7):4200-7. PubMed ID: 19299718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of TCR specificity and clonal competition during reconstruction of the peripheral T cell pool.
    Leitão C; Freitas AA; Garcia S
    J Immunol; 2009 May; 182(9):5232-9. PubMed ID: 19380769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing.
    Gregerson DS; Lew KL; McPherson SW; Heuss ND; Ferrington DA
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5385-94. PubMed ID: 17122128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
    Waeckerle-Men Y; Starke A; Wüthrich RP
    Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell activation correlates with an increased proportion of antigen among the materials acquired from target cells.
    Hudrisier D; Riond J; Garidou L; Duthoit C; Joly E
    Eur J Immunol; 2005 Aug; 35(8):2284-94. PubMed ID: 16021601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection.
    Kapp JA; Honjo K; Kapp LM; Xu Xy; Cozier A; Bucy RP
    Int Immunol; 2006 Nov; 18(11):1549-62. PubMed ID: 16966495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific CD4+ effector T cells: analysis of factors regulating clonal expansion and cytokine production: clonal expansion and cytokine production by CD4+ effector T cells.
    Ohnuki K; Watanabe Y; Takahashi Y; Kobayashi S; Watanabe S; Ogawa S; Kotani M; Kozono H; Tanabe K; Abe R
    Biochem Biophys Res Commun; 2009 Mar; 380(4):742-7. PubMed ID: 19338745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes.
    Love VA; Grabie N; Duramad P; Stavrakis G; Sharpe A; Lichtman A
    Circ Res; 2007 Aug; 101(3):248-57. PubMed ID: 17569889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses.
    Xiao Z; Curtsinger JM; Prlic M; Jameson SC; Mescher MF
    Int Immunol; 2007 Jun; 19(6):733-43. PubMed ID: 17545279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation.
    van Stipdonk MJ; Lemmens EE; Schoenberger SP
    Nat Immunol; 2001 May; 2(5):423-9. PubMed ID: 11323696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining control parameters for dendritic cell-cytotoxic T lymphocyte interaction.
    Ludewig B; Krebs P; Junt T; Metters H; Ford NJ; Anderson RM; Bocharov G
    Eur J Immunol; 2004 Sep; 34(9):2407-18. PubMed ID: 15307173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR2 engagement on CD8 T cells enables generation of functional memory cells in response to a suboptimal TCR signal.
    Mercier BC; Cottalorda A; Coupet CA; Marvel J; Bonnefoy-Bérard N
    J Immunol; 2009 Feb; 182(4):1860-7. PubMed ID: 19201838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
    Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
    J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.